Top news of March: William Shatner, DEI, cancer-causing acne products
Click Here to Manage Email Alerts
Healio has compiled March’s most-read news in dermatology.
Presentations and news from the American Academy of Dermatology Annual Meeting dominated headlines, as well as breaking news regarding benzoyl peroxide.
After stage 4 melanoma diagnosis, treatment, William Shatner shares new outlook on life
During a presentation at the American Academy of Dermatology Annual Meeting, William Shatner, most famous for his portrayal of Captain James T. Kirk in the Star Trek franchise, vividly recalled the moment he learned a simple lump under his right ear, initially dismissed, was in fact cancer, and how concern from a caring physician likely saved his life. Read more.
Atopic dermatitis treatments with greatest efficacy may also cause most harm
The most effective treatments for atopic dermatitis proved to potentially be the most harmful, with upadacitinib topping the list, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting. Read more.
AAD Advisory Board rejects resolution to end DEI programs
On March 20, the American Academy of Dermatology’s Advisory Board voted to not adopt the resolution to dismantle and remove all current diversity, equity and inclusion programs. Terrence A. Cronin Jr., MD, FAAD, president of the AAD, gave a statement to Healio. Read more.
Valisure warns acne treatments can create cancer-causing benzene
On March 6, the news broke that acne products containing benzoyl peroxide develop high levels of benzene, a potentially cancer-causing chemical, when handled or stored at higher temperatures, according to a report from the independent laboratory Valisure. Read more.
Mending racial inequities in health care starts with ‘being a good human being’
In her standing ovation-received keynote address at the 20th Annual Skin of Color Society Scientific Symposium, Aletha Maybank, MD, MPH, senior vice president and chief health equity officer of the American Medical Association, discussed how racial inequities in society and health care is a moral issue before it is a scientific one. Read more.
Military members, veterans face increased risk for melanoma
In a press release, the American Academy of Dermatology discussed how U.S. military members and veterans face an increased risk of developing melanoma due to occupational hazards such as where they are stationed or in which branch of the military they serve. Read more.
Oral roflumilast treatment may induce weight loss in patients with psoriasis
Treating psoriasis with oral roflumilast proved to induce weight loss, positioning the drug as a potentially attractive alternative for patients with psoriasis, according to a study published in the Journal of the American Academy of Dermatology. Read more.
FDA accepts new drug application for DFD-29 for rosacea treatment
On March 18, the FDA accepted Journey Medical’s new drug application for oral DFD-29 (minocycline hydrochloride modified release capsules 40 mg) for the treatment of rosacea and set a PDUFA date of Nov. 4. Read more.
Most prescribers favor oral minoxidil for androgenetic alopecia
In a survey, prescribers expressed an overall positive opinion toward the off-label use of low-dose oral minoxidil for the treatment of androgenetic alopecia; however, opinions varied based on years of experience, according to a study published in the Journal of Drugs and Dermatology. Read more.
Physician shares alternative medicine practices for hidradenitis suppurativa
During her presentation at the American Academy of Dermatology, Vivian Shi, MD, FAAD, associate professor of dermatology at University of Arkansas for Medical Sciences, discussed how dietary modifications, supplementation and other lifestyle changes can significantly improve hidradenitis suppurativa. She shared her expertise with Healio. Read more.